Neuropathology of chronic GM2 gangliosidosis due to hexosaminidase A deficiency - PubMed (original) (raw)
Case Reports
. 2008 Sep-Oct;27(5):302-8.
doi: 10.5414/npp27302.
Affiliations
- PMID: 18808061
- DOI: 10.5414/npp27302
Case Reports
Neuropathology of chronic GM2 gangliosidosis due to hexosaminidase A deficiency
M Kornfeld. Clin Neuropathol. 2008 Sep-Oct.
Abstract
Autopsy studies of late-onset GM2 gangliosidosis are sparse and only one adult case is on record. The case of partial Hex A deficiency presented here started in childhood as spinal muscular atrophy which progressed slowly over 4 decades. Cognitive function remained intact throughout the entire course, but during the last few years of life allodynia supervened. The patient died at 44 years of age. In good correlation with clinical observations the autopsy findings showed the most severe accumulation of lipid and consequent regressive change in the anterior horns of the spinal cord. Extensive but less severe storage was found in other spinal cord neurons, brain stem and selected basal ganglia. Cerebral cortex was virtually spared by storage but was the site of excessive formation of lipofuscin which was also present in many other neurons in the CNS. Marked storage and ganglionic loss was also found in the dorsal root ganglia, and the fasciculus gracilis was severely depleted of myelinated fibers. Electron microscopy showed accumulated gangliosides almost exclusively in the form of single and coalescing zebra bodies. In conclusion, the pathology in this case of chronic GM2 gangliosidosis, though in part conforming with previous observations, differed in several aspects. First, the cerebral cortex was--with only a few exceptions--free of ganglioside storage. Also spared was the cerebellum. In addition, homogeneous accumulation of zebra bodies contrasted with heterogeneity of neuronal inclusions found in other chronic cases. Finally, the involvement of sensory neurons was prominent and potentially related to allodynia. Molecular study of HEXA gene in this patient showed an TATC1278/? genotype.
Similar articles
- A pathogenic HEXA missense variant in wild boars with Tay-Sachs disease.
Bertani V, Prioni S, Di Lecce R, Gazza F, Ragionieri L, Merialdi G, Bonilauri P, Jagannathan V, Grassi S, Cabitta L, Paoli A, Morrone A, Sonnino S, Drögemüller C, Cantoni AM. Bertani V, et al. Mol Genet Metab. 2021 Jul;133(3):297-306. doi: 10.1016/j.ymgme.2021.05.001. Epub 2021 May 7. Mol Genet Metab. 2021. PMID: 34119419 - GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease.
Demir SA, Timur ZK, Ateş N, Martínez LA, Seyrantepe V. Demir SA, et al. J Neuroinflammation. 2020 Sep 20;17(1):277. doi: 10.1186/s12974-020-01947-6. J Neuroinflammation. 2020. PMID: 32951593 Free PMC article. - Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ, Trasler JM, Igdoura S, Michaud J, Hanal N, Gravel RA. Huang JQ, et al. Hum Mol Genet. 1997 Oct;6(11):1879-85. doi: 10.1093/hmg/6.11.1879. Hum Mol Genet. 1997. PMID: 9302266 - Neuropathology of late onset gangliosidoses. A review.
Suzuki K. Suzuki K. Dev Neurosci. 1991;13(4-5):205-10. doi: 10.1159/000112161. Dev Neurosci. 1991. PMID: 1817025 Review. - The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
Maegawa GH, Stockley T, Tropak M, Banwell B, Blaser S, Kok F, Giugliani R, Mahuran D, Clarke JT. Maegawa GH, et al. Pediatrics. 2006 Nov;118(5):e1550-62. doi: 10.1542/peds.2006-0588. Epub 2006 Oct 2. Pediatrics. 2006. PMID: 17015493 Free PMC article. Review.
Cited by
- Clinical and imaging predictors of late-onset GM2 gangliosidosis: A scoping review.
Godbole NP, Haxton E, Rowe OE, Locascio JJ, Schmahmann JD, Eichler FS, Ratai EM, Stephen CD. Godbole NP, et al. Ann Clin Transl Neurol. 2024 Jan;11(1):207-224. doi: 10.1002/acn3.51947. Epub 2023 Nov 27. Ann Clin Transl Neurol. 2024. PMID: 38009419 Free PMC article. Review. - Natural history of Tay-Sachs disease in sheep.
Story B, Taghian T, Gallagher J, Koehler J, Taylor A, Randle A, Nielsen K, Gross A, Maguire A, Carl S, Johnson S, Fernau D, Diffie E, Cuddon P, Corado C, Chandra S, Sena-Esteves M, Kolodny E, Jiang X, Martin D, Gray-Edwards H. Story B, et al. Mol Genet Metab. 2021 Sep-Oct;134(1-2):164-174. doi: 10.1016/j.ymgme.2021.08.009. Epub 2021 Aug 21. Mol Genet Metab. 2021. PMID: 34456134 Free PMC article. - The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.
Toro C, Zainab M, Tifft CJ. Toro C, et al. Neurosci Lett. 2021 Nov 1;764:136195. doi: 10.1016/j.neulet.2021.136195. Epub 2021 Aug 25. Neurosci Lett. 2021. PMID: 34450229 Free PMC article. No abstract available. - Genetics and Therapies for GM2 Gangliosidosis.
Cachon-Gonzalez MB, Zaccariotto E, Cox TM. Cachon-Gonzalez MB, et al. Curr Gene Ther. 2018;18(2):68-89. doi: 10.2174/1566523218666180404162622. Curr Gene Ther. 2018. PMID: 29618308 Free PMC article. Review. - Young-onset dementia.
Kuruppu DK, Matthews BR. Kuruppu DK, et al. Semin Neurol. 2013 Sep;33(4):365-85. doi: 10.1055/s-0033-1359320. Epub 2013 Nov 14. Semin Neurol. 2013. PMID: 24234358 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical